Achilles tendinitis

M13_ACHILLESTEND

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76.6 Hospital discharge: ICD-9 — 7267A Cause of death: ICD-10 — M76.6 Cause of death: ICD-9 — 7267A 2 out of 7 registries used, show all original rules.	4462
4. Check minimum number of events None	4462
5. Include endpoints None	4462
6. Filter based on genotype QC (FinnGen only)	4462

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M76
Name in latin: Tendinitis tendinis Achillis

NAME	M13_ACHILLESTEND
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M766
HD_ICD_9	7267A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M766
COD_ICD_9	7267A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Achilles tendinitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26379	12438	13852
Only index persons	25665	12199	13466
Unadjusted period prevalence (%)
Whole population	0.37	0.36	0.39
Only index persons	0.48	0.45	0.51
Median age at first event (years)
Whole population	50.12	51.73	48.70
Only index persons	50.02	51.68	48.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4462	2399	2063
Unadjusted period prevalence (%)	0.86	0.82	0.91
Median age at first event (years)	53.13	52.44	53.93

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4002: Matched controls
40018

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

7267A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[TENDINITIS SEU BURSITIS ACHILLIS]

+∞

323.3

306

M76.6

ICD-10 Finland

Achilles tendinitis

1352.3

323.0

3748

438

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

643.3

323.0

981

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

30.2

323.0

623

243

M48.0

ICD-10 Finland

Spinal stenosis

37.6

322.3

416

123

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

18.5

253.5

403

241

M01AH05

ATC

etoricoxib; oral

3.2

252.1

2799

16820

S86.0

ICD-10 Finland

Injury of Achilles tendon

13.8

247.0

443

358

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

21.9

224.5

336

167

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

24.1

220.0

319

143

M54.5

ICD-10 Finland

Low back pain

3.4

212.5

1299

4939

N02AX02

ATC

tramadol; systemic, rectal

2.9

205.0

1816

8891

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.8

202.6

2082

11164

N03AX16

ATC

pregabalin; oral

3.8

197.4

996

3218

M54.4

ICD-10 Finland

Lumbago with sciatica

5.4

192.3

639

1364

M02AA07

ATC

piroxicam; topical

2.8

189.8

1778

8886

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

50.4

184.5

224

L16

ICPC

Ankle symptom/complaint

4.7

180.9

687

1689

M79.6

ICD-10 Finland

Pain in limb

2.8

173.4

1588

7710

M01AB05

ATC

diclofenac; systemic, rectal

2.6

160.0

2895

20156

M25.5

ICD-10 Finland

Pain in joint

2.8

158.5

1332

6060

M01AC06

ATC

meloxicam; systemic, rectal

2.6

155.9

1686

8864

N03AX12

ATC

gabapentin; oral

4.4

149.2

608

1582

NHL10

NOMESCO Finland

Suture or reinsertion of achilles tendon

15.6

146.1

246

167

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

15.3

143.2

243

168

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

64.1

142.4

166

N02AJ06

ATC

codeine and paracetamol; systemic

2.5

139.8

1596

8498

M03BX02

ATC

tizanidine; oral

2.3

131.8

2570

17598

9477

FHL

Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)

48.0

128.3

157

M01AE02

ATC

naproxen; oral, rectal

2.2

125.3

2356

15684

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.7

124.1

336

542

N02BE01

ATC

paracetamol; systemic, rectal

2.7

119.3

3440

27803

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.3

117.0

385

791

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.7

116.1

946

4089

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.6

112.9

1049

4879

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

94.3

107.6

119

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

1034.4

103.7

101

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

23.6

103.4

150

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

18.1

102.3

162

M01AX17

ATC

nimesulide; oral

2.4

98.2

1043

5145

M02AA10

ATC

ketoprofen; topical

2.7

98.1

762

3162

NH4AE

NOMESCO Finland

Achilles tendon ultrasound examination

33.9

97.4

128

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

97.1

942

4428

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

96.3

1548

9235

L17

ICPC

Foot/toe symptom/complaint

2.4

95.1

1039

5185

M01AE01

ATC

ibuprofen; systemic, rectal

2.8

94.9

3639

31240

M01AH01

ATC

celecoxib; oral (coxibs)

2.6

93.1

771

3312

M47.82

ICD-10 Finland

Other spondylosis, cervical region

17.7

90.4

144

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

89.0

1092

5733

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

86.8

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

856.2

85.9

L03

ICPC

Low back symptom/complaint

2.5

85.9

822

3807

M70.6

ICD-10 Finland

Trochanteric bursitis

3.3

85.8

490

1645

M54.3

ICD-10 Finland

Sciatica

7.7

85.7

207

281

A02BC02

ATC

pantoprazole; systemic

1.9

85.5

2500

18483

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

11.1

84.9

166

156

M01AH02

ATC

rofecoxib; oral

2.9

83.9

562

2107

H02AB06

ATC

prednisolone; systemic

1.9

81.7

1788

11808

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.9

81.6

366

1013

M43.1

ICD-10 Finland

Spondylolisthesis

21.7

80.8

120

J01DB01

ATC

cefalexin; oral

2.1

80.6

3248

26814

A02BC05

ATC

esomeprazole; systemic

1.9

78.0

1576

10050

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.2

76.0

450

1544

WX320

NOMESCO Finland

Spinalanesthesy

2.2

74.2

970

5170

J01AA02

ATC

doxycycline; systemic

2.0

73.9

3082

25177

B01AB05

ATC

enoxaparin; parenteral

2.0

73.7

1227

7230

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.7

73.5

569

2320

M01AX05

ATC

glucosamine; oral

2.3

72.2

772

3742

J01FA10

ATC

azithromycin; systemic

1.8

70.5

2270

16793

R03AC02

ATC

salbutamol; inhalant

1.8

70.3

1976

13969

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

+∞

70.0

M47.9

ICD-10 Finland

Spondylosis, unspecified

22.0

69.8

103

M54.2

ICD-10 Finland

Cervicalgia

4.8

69.6

247

545

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.6

68.6

574

2443

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.2

68.5

385

1270

A02BC03

ATC

lansoprazole; oral

2.0

66.2

1093

6364

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.8

63.9

167

254

ZXA00

NOMESCO Finland

Right side

2.0

63.6

1064

6211

L15

ICPC

Knee symptom/complaint

2.1

62.8

816

4296

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

35.9

62.7

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

62.6

M45

ICD-10 Finland

Ankylosing spondylitis

48.3

62.6

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

62.0

742

3764

R01AD09

ATC

mometasone; nasal

1.8

61.8

1729

12021

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

61.7

1228

7621

S18

ICPC

Laceration/cut

1.8

61.5

1580

10687

N06AX21

ATC

duloxetine; oral

3.0

61.1

389

1395

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

12.9

59.4

107

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

59.0

816

4396

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.3

58.1

318

1026

N06AA09

ATC

amitriptyline; systemic

3.0

57.9

361

1274

ZXA05

NOMESCO Finland

Left side

1.9

57.9

978

5693

9211

FHL

Exploration or removal of diskusprolapse

199.5

57.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

56.0

584

2765

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

55.1

512

2284

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

54.6

1001

5984

NH2AA

NOMESCO Finland

Heel X-ray examination

14.1

54.4

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

280.0

54.3

X58

ICD-10 Finland

Exposure to other specified factors

2.3

54.1

562

2652

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

53.4

345

1244

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

10.0

53.3

109

112

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

52.6

1049

6442

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.0

52.5

324

1135

H02AB04

ATC

methylprednisolone; systemic

2.2

52.4

577

2798

M54.1

ICD-10 Finland

Radiculopathy

8.8

51.4

113

132

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

51.2

434

1844

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

51.1

1527

10636

J01FA06

ATC

roxithromycin; oral

1.7

51.0

1529

10659

M76.7

ICD-10 Finland

Peroneal tendinitis

19.4

51.0

J01DA01

ATC

[U] cefalexin; systemic

1.7

50.3

2344

18456

L13

ICPC

Hip symptom/complaint

2.2

50.1

550

2657

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

50.0

1924

14365

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

49.4

634

3284

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.0

49.4

299

1033

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

49.3

496

2298

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

48.1

625

3251

R51.80

ICD-10 Finland

Headache

2.3

47.5

484

2255

M79.1

ICD-10 Finland

Myalgia

2.3

47.5

464

2118

R06.0

ICD-10 Finland

Dyspnoea

1.9

47.3

803

4635

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.0

46.9

294

1036

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

46.3

761

4334

J01MA02

ATC

ciprofloxacin; systemic

1.7

45.9

1391

9647

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

22.0

45.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

45.6

431

1931

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

12.7

45.4

L08

ICPC

Shoulder symptom/complaint

2.0

45.2

674

3695

SPAT1153

SPAT

Removal of sutures

1.7

44.7

1144

7539

J01FF01

ATC

clindamycin; systemic

1.8

44.5

1023

6521

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.9

44.1

284

1021

J01CA04

ATC

amoxicillin; systemic

1.7

44.0

3045

26150

R01AD12

ATC

fluticasone furoate; nasal

1.7

43.1

1095

7184

M01AC01

ATC

piroxicam; systemic, rectal

2.1

42.9

524

2644

UJF32

NOMESCO Finland

Coloscopy

1.8

42.5

889

5486

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.5

42.4

368

1576

Z3226

NOMESCO Finland

Physiotherapist

2.0

42.3

659

3667

M76.0

ICD-10 Finland

Gluteal tendinitis

8.4

42.2

116

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

41.9

986

6312

R01AD08

ATC

fluticasone; nasal

1.7

41.8

1055

6898

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

41.7

701

4010

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

41.7

898

5586

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

41.7

M54.6

ICD-10 Finland

Pain in thoracic spine

3.5

41.6

206

614

M01AB55

ATC

diclofenac, combinations; oral

3.0

41.3

255

891

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

5.8

41.1

120

212

S83.2

ICD-10 Finland

Tear of meniscus, current

2.6

41.1

317

1272

R06AE07

ATC

cetirizine; oral

1.6

40.8

1554

11355

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

144.8

40.8

G47.3

ICD-10 Finland

Sleep apnoea

1.8

40.8

831

5075

M43.0

ICD-10 Finland

Spondylolysis

45.0

40.0

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

48.5

39.8

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.4

39.6

149

349

M50.3

ICD-10 Finland

Other cervical disc degeneration

14.2

39.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

39.1

549

2929

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

12.0

39.0

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

106.1

38.8

J02AC01

ATC

fluconazole; systemic

1.6

38.4

1418

10238

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

38.2

2062

16311

A02BC01

ATC

omeprazole; systemic

1.7

38.1

912

5841

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

37.8

318

1337

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.4

37.7

343

1500

M77.4

ICD-10 Finland

Metatarsalgia

3.0

37.7

226

772

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

37.6

2620

21968

Z50.1

ICD-10 Finland

Other physical therapy

3.1

37.3

216

723

E66.8

ICD-10 Finland

Other obesity

2.9

37.2

234

826

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

6.9

37.1

138

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.5

36.9

136

312

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.2

36.5

402

1930

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.3

36.4

374

1741

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

36.3

743

4523

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

36.3

387

1832

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

36.2

2326

19048

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

9.3

36.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

36.1

1758

13507

R03BA02

ATC

budesonide; inhalant

1.9

36.0

620

3561

M01AH03

ATC

valdecoxib; oral

2.7

35.9

264

1027

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.0

35.9

220

765

L86

ICPC

Back syndrome with radiating pain

3.9

35.9

155

413

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

35.8

402

1945

J01FA09

ATC

clarithromycin; systemic

1.6

35.7

1171

8161

R03DC03

ATC

montelukast; oral

1.9

35.6

576

3235

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.7

35.5

105

189

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

35.4

2129

17134

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

35.4

596

3395

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

350.2

35.0

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

34.8

319

1401

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

34.6

1427

10512

A02BA02

ATC

ranitidine; systemic

1.8

34.3

649

3843

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

34.3

653

3874

R03BA05

ATC

fluticasone; inhalant

1.8

34.1

630

3699

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.0

34.1

211

736

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

34.0

254

999

G44.2

ICD-10 Finland

Tension-type headache

2.1

34.0

418

2104

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

33.8

1422

10508

H02BX01

ATC

methylprednisolone, combinations; systemic

3.0

33.8

205

708

L28

ICPC

Limited function/disability (L)

2.0

33.4

444

2308

R42

ICD-10 Finland

Dizziness and giddiness

1.8

33.1

650

3892

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

33.1

783

4966

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

20.6

33.0

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

32.8

1914

15190

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.3

32.7

324

1477

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

32.4

1143

8077

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.5

32.2

183

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.7

32.1

230

881

R52.9

ICD-10 Finland

Pain, unspecified

2.4

32.0

290

1265

NGL50

NOMESCO Finland

319.5

31.9

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

31.8

303

1356

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

31.7

427

2230

M01AB08

ATC

etodolac; oral

2.4

31.7

285

1239

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

31.7

826

5381

SPAT1263

SPAT

Sampling

1.5

31.6

1416

10571

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

31.4

1350

9982

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.7

31.2

230

897

M01AB01

ATC

indometacin; systemic, rectal

2.4

31.1

278

1203

M01AX01

ATC

nabumetone; oral

3.2

30.6

165

525

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

7.8

30.6

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

29.8

1625

12620

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

29.5

1337

9971

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

29.4

553

3254

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.2

29.4

304

1414

L01

ICPC

Neck symptom/complaint

2.0

29.1

409

2168

D01BA02

ATC

terbinafine; oral; topical

1.6

29.1

940

6465

A07EC01

ATC

sulfasalazine; oral, rectal

2.3

29.0

271

1200

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

29.0

260

1129

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.8

29.0

198

739

R4110

NOMESCO Finland

Physiotherapy

1.6

28.8

911

6228

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

293.9

28.8

M71.5

ICD-10 Finland

Other bursitis, not elsewhere classified

14.7

28.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

28.6

1423

10807

Z01.2

ICD-10 Finland

Dental examination

1.5

28.6

1446

11021

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

10.0

28.3

R60.0

ICD-10 Finland

Localized oedema

2.1

28.3

352

1777

M77.1

ICD-10 Finland

Lateral epicondylitis

2.3

28.3

271

1216

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

28.1

1950

15838

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

28.1

1244

9205

WX110

NOMESCO Finland

Local anesthesy

1.5

28.0

2504

21374

K02.1

ICD-10 Finland

Caries of dentine

1.4

28.0

2021

16537

L14

ICPC

Leg/thigh symptom/complaint

2.4

27.7

245

1053

N06AX11

ATC

mirtazapine; oral

1.6

27.5

1014

7181

M79.7

ICD-10 Finland

Fibromyalgia

3.9

27.5

116

304

A01

ICPC

Pain general/multiple sites

2.5

27.4

225

931

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

27.3

355

1825

M09AX01

ATC

hyaluronic acid; parenteral

2.9

27.3

177

637

XA402

NOMESCO Finland

ENMG

4.7

27.2

203

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

27.1

N02AA05

ATC

oxycodone; systemic

1.9

27.0

410

2234

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

8.3

27.0

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

27.0

249

1096

1220

FHL

Arthroscopy

2.9

26.8

167

588

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

26.2

280

1321

R03AC03

ATC

terbutaline; inhalant

1.8

26.2

469

2708

R05FB02

ATC

cough suppressants and expectorants

1.5

26.2

1296

9784

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.1

26.1

104

259

P01AB01

ATC

metronidazole; oral, rectal

1.5

25.9

1349

10286

N05CF01

ATC

zopiclone; oral

1.5

25.9

1014

7267

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.4

25.9

9476

FHL

Splitting of fascia or aponeurosis

9.4

25.6

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

25.6

932

6563

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

25.6

958

6795

L02

ICPC

Back symptom/complaint

2.3

25.5

258

1186

SPAT1310

SPAT

Counselling related to known health issue

1.5

25.5

1034

7468

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

25.3

886

6179

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

25.2

264

1235

M54

ICD-10 Finland

Dorsalgia

2.0

25.2

320

1629

S86.3

ICD-10 Finland

Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level

5.9

25.2

122

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

25.1

953

6774

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

25.1

300

1487

AA1AD

NOMESCO Finland

CT of head and brain

1.6

25.1

709

4687

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.4

25.1

229

1004

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.5

24.7

196

798

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

24.6

238

1071

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.6

24.5

185

731

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

5.0

24.5

159

UKC02

NOMESCO Finland

Cystoscopy

1.8

24.5

493

2952

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

24.3

394

2198

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

24.2

244

1121

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

24.1

325

1692

B01AF01

ATC

rivaroxaban; oral

1.9

24.1

394

2200

WX290

NOMESCO Finland

Other blockade of nerve

1.4

24.0

1523

12025

D07AC01

ATC

betamethasone; topical

1.5

24.0

1167

8743

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

24.0

309

1580

NH4AE

SPAT

17.8

23.9

R52.2

ICD-10 Finland

Other chronic pain

3.8

23.9

103

276

Z71.8

ICD-10 Finland

Other specified counselling

1.6

23.9

756

5140

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

23.8

455

2680

J01MA12

ATC

levofloxacin; systemic

1.7

23.8

610

3922

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

5.3

23.8

139

R06AX27

ATC

desloratadine; oral

1.5

23.8

886

6259

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

23.7

661

4346

M54.8

ICD-10 Finland

Other dorsalgia

3.5

23.7

115

340

Z00.0

ICD-10 Finland

General medical examination

1.7

23.6

596

3816

KMAK

NOMESCO Finland

1.4

23.6

1830

14981

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.2

23.5

261

1253

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

9.9

23.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

23.4

325

1710

R05

ICPC

Cough

1.6

23.4

710

4769

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

21.4

23.4

N03AE01

ATC

clonazepam; systemic

2.5

23.3

185

754

ACC51

NOMESCO Finland

Release of median nerve

2.2

23.3

245

1149

C03CA01

ATC

furosemide; systemic

1.6

23.0

734

4991

E0000UV

ATC

1.4

23.0

1299

10005

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

23.0

357

1961

M75.2

ICD-10 Finland

Bicipital tendinitis

3.8

22.8

267

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.8

22.7

148

537

Z3231

NOMESCO Finland

Registered nurse

1.5

22.7

905

6485

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.4

22.7

199

855

S29

ICPC

Skin symptom/complaint other

1.7

22.6

534

3351

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.8

22.6

264

SPAT1211

SPAT

Application of soft bandage

2.0

22.5

290

1483

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.9

22.3

357

1978

K30

ICD-10 Finland

Functional dyspepsia

1.9

22.2

328

1768

M77.3

ICD-10 Finland

Calcaneal spur

5.9

22.2

106

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

22.1

114

353

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

21.9

J02AC02

ATC

itraconazole; systemic

1.6

21.8

638

4241

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

21.6

439

2636

N05CF02

ATC

zolpidem; oral

1.6

21.5

575

3734

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

31.3

21.5

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.6

21.4

160

631

M04AA01

ATC

allopurinol; systemic

1.8

21.4

391

2269

G04BD12

ATC

mirabegron; oral

1.9

21.3

305

1625

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

21.2

810

5731

L29

ICPC

Musculoskeletal sympt/complt other

2.1

21.2

237

1141

R07.3

ICD-10 Finland

Other chest pain

2.0

21.1

279

1442

H02AB07

ATC

prednisone; oral

1.7

21.0

455

2781

C08CA01

ATC

amlodipine; oral

1.4

21.0

1129

8578

A02BC04

ATC

rabeprazole; oral

2.0

21.0

278

1437

R06AX22

ATC

ebastine; oral

1.6

20.9

585

3843

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

20.9

267

1362

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

20.8

239

1163

D19

ICPC

Teeth/gum symptom/complaint

1.5

20.8

885

6416

WZA90

NOMESCO Finland

Other doctors statement

1.5

20.7

731

5079

ZXE00

NOMESCO Finland

One hour or less

1.4

20.7

1339

10531

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

77.2

20.7

L90

ICPC

Osteoarthrosis of knee

2.2

20.7

207

948

N06AX16

ATC

venlafaxine; oral

1.7

20.7

427

2575

N04BC05

ATC

pramipexole; oral

2.2

20.6

212

983

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

20.5

468

2903

M23.8

ICD-10 Finland

Other internal derangements of knee

2.8

20.5

138

510

M22.4

ICD-10 Finland

Chondromalacia patellae

3.0

20.5

119

401

R96

ICPC

Asthma

2.0

20.5

266

1365

M75.8

ICD-10 Finland

Other shoulder lesions

3.0

20.5

118

396

R03BA08

ATC

ciclesonide; inhalant

2.0

20.4

276

1439

NH1BG

SPAT

6.7

20.1

SPAT1301

SPAT

No procedures

1.5

20.1

942

6959

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

20.0

1448

11593

1221

FHL

Arthroscopy and meniscus surgery

3.0

20.0

117

397

M01AE52

ATC

naproxen and esomeprazole; oral

2.9

20.0

123

432

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

19.9

741

5205

N02AJ13

ATC

tramadol and paracetamol; systemic

4.8

19.9

138

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

19.9

393

2334

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

19.9

301

1634

L12

ICPC

Hand/finger symptom/complaint

1.7

19.9

428

2612

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.6

19.9

263

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

19.8

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

19.8

N06AB04

ATC

citalopram; systemic

1.5

19.8

669

4598

N06AA10

ATC

nortriptyline; systemic

4.2

19.8

180

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

19.8

296

1600

R02

ICPC

Shortness of breath/dyspnoea

1.8

19.7

335

1894

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

19.6

212

1003

R74

ICPC

Upper respiratory infection acute

1.5

19.6

866

6310

C07AB07

ATC

bisoprolol; oral

1.4

19.5

1462

11761

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

19.4

1667

13721

C09CA06

ATC

candesartan; oral

1.5

19.4

716

5019

G54.0

ICD-10 Finland

Brachial plexus disorders

4.4

19.4

165

TAB20

NOMESCO Finland

Epidural puncture

15.6

19.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

19.1

550

3631

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

19.1

191

875

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.7

19.0

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

19.0

806

5821

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

19.0

166

713

ZXD20

NOMESCO Finland

Day surgery

1.7

18.8

439

2739

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

18.8

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

+∞

18.8

7276F

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUMATICA TENDINIS ACHILLEI]

11.8

18.7

M01AC02

ATC

tenoxicam; systemic, rectal

2.3

18.7

175

775

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

18.7

974

7328

J01FA15

ATC

telithromycin; oral

1.8

18.6

364

2154

SPAT1229

SPAT

Assessment of need for aid

2.1

18.5

218

1072

J01DA06

ATC

[U] cefuroxime; systemic

1.6

18.5

493

3188

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.7

18.5

130

495

J01FA01

ATC

erythromycin; systemic

1.7

18.4

440

2764

N02AC04

ATC

dextropropoxyphene; oral

3.2

18.4

301

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.9

18.3

116

414

R35

ICD-10 Finland

Polyuria

2.2

18.2

193

909

M77.5

ICD-10 Finland

Other enthesopathy of foot

6.3

18.2

R5599

NOMESCO Finland

Other rehabilitation service

3.5

18.1

241

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

18.1

169

750

SPAT1216

SPAT

Assessment of functional ability

1.7

18.0

396

2428

C10AA05

ATC

atorvastatin; oral

1.4

18.0

1231

9715

S80.0

ICD-10 Finland

Contusion of knee

2.1

18.0

208

1018

G04CA02

ATC

tamsulosin; oral

1.5

17.8

630

4365

9489

FHL

Other measure in this category

22.9

17.7

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

+∞

17.7

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.6

17.7

220

R05

ICD-10 Finland

Cough

1.5

17.5

590

4045

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.5

17.4

138

563

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

17.4

656

4609

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.6

17.4

131

520

J01EA01

ATC

trimethoprim; systemic

1.5

17.4

716

5125

A02BA04

ATC

nizatidine; systemic

2.0

17.3

229

1183

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

17.3

1252

9962

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

17.3

280

1559

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

13.9

17.2

L84

ICPC

Back syndrome without radiat pain

2.7

17.2

120

456

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.3

17.2

160

708

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

17.2

816

6011

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

6.8

17.2

WX002

NOMESCO Finland

Sedation and analgesia

1.5

17.2

630

4395

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

17.2

127

499

9481

FHL

Detachment or severance of a muscle or tendon

8.1

17.2

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

17.1

905

6808

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

17.1

647

4546

L87

ICPC

Bursitis/tendinitis/synovitis NOS

4.1

17.1

167

A03FA02

ATC

cisapride; oral, rectal

2.0

17.0

218

1113

SPAT1312

SPAT

General health counselling

1.4

16.9

978

7478

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

16.9

299

1714

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.9

16.9

105

373

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

16.8

178

837

P01BA02

ATC

hydroxychloroquine; oral

1.9

16.7

252

1367

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

16.7

236

1250

-1

NOMESCO Finland

1.4

16.7

1071

8339

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

16.7

1261

10092

R06AE09

ATC

levocetirizine; oral

1.6

16.5

471

3094

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

16.4

218

1129

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

16.4

630

4442

R13

ICD-10 Finland

Dysphagia

2.1

16.4

180

863

S06.0

ICD-10 Finland

Concussion

1.8

16.3

284

1618

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.9

16.3

101

358

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

16.2

893

6760

NBG10

NOMESCO Finland

Acromioplastia

3.0

16.2

330

B01AX06

ATC

[U] rivaroxaban; oral

3.3

16.2

258

R06.5

ICD-10 Finland

Mouth breathing

1.8

16.2

294

1697

9478

FHL

Tendoraphy or reconstruction, e.g., graft, reflex, tenodesis

5.5

16.1

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

16.1

155

699

D01

ICPC

Abdominal pain/cramps general

1.8

16.0

291

1683

T93.5

ICD-10 Finland

Sequelae of injury of muscle and tendon of lower limb

11.7

16.0

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

6.2

15.9

R03BA01

ATC

beclometasone; inhalant

1.6

15.9

422

2726

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.8

15.8

174

C01CA24

ATC

epinephrine; parenteral

2.0

15.8

198

1001

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

15.8

382

2407

ZXD05

NOMESCO Finland

Urgent procedure

1.4

15.7

940

7216

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.8

15.7

102

372

M53.2

ICD-10 Finland

Spinal instabilities

33.5

15.7

9102

FHL

Trepanation or removal of the local bone process

5.9

15.7

H01

ICPC

Ear pain/earache

1.8

15.7

291

1693

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

15.6

XKD00

NOMESCO Finland

Uroflowmetry

1.6

15.6

464

3080

L18

ICPC

Muscle pain

2.6

15.6

116

457

C05AA08

ATC

fluocortolone; rectal, topical

1.6

15.6

461

3056

M20.2

ICD-10 Finland

Hallux rigidus

2.6

15.6

116

458

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

15.6

378

2381

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

19.3

15.5

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

15.5

347

2138

SPAT1210

SPAT

Application of cast or individual aid

2.3

15.3

137

597

K08.80

ICD-10 Finland

Toothache NOS

1.9

15.3

246

1364

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

15.2

589

4153

M77.0

ICD-10 Finland

Medial epicondylitis

3.1

15.2

271

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.4

15.2

217

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

15.2

678

4926

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

15.2

352

2190

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

15.2

374

2365

R03AC12

ATC

salmeterol; inhalant

2.4

15.1

129

546

M19.8

ICD-10 Finland

Other specified arthrosis

2.6

15.1

111

436

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

15.1

2455

21890

N05BA01

ATC

diazepam; systemic, rectal

1.6

15.1

380

2417

H92.0

ICD-10 Finland

Otalgia

2.3

15.1

146

660

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

15.1

180

895

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

4.6

15.0

111

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.3

15.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

14.9

451

3006

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

14.9

878

6714

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.8

14.9

338

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.5

14.8

113

454

M41.9

ICD-10 Finland

Scoliosis, unspecified

11.3

14.7

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

14.7

154

723

R21

ICPC

Throat symptom/complaint

1.5

14.7

537

3736

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

14.7

325

1996

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

14.7

1218

9847

D07AD01

ATC

clobetasol; topical

1.5

14.7

500

3425

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.4

14.6

208

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

14.6

E000001

ATC

1.5

14.6

601

4290

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

14.6

189

971

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

14.5

240

1345

B01AA03

ATC

warfarin; systemic

1.5

14.5

513

3547

J01MA14

ATC

moxifloxacin; systemic

1.7

14.5

279

1646

7177A

ICD-9 Finland

Internal derangement of knee, Chondromalacia of patella

4.1

14.5

139

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

14.4

179

901

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.1

14.4

168

825

M76.5

ICD-10 Finland

Patellar tendinitis

4.9

14.4

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

14.4

312

1904

M35.7

ICD-10 Finland

Hypermobility syndrome

5.8

14.3

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

3286

25701

2.06

95.05

4.8

3.6

mm/h

11.6

11.9

0.82

3086

23756

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

954

5025

2.14

85.49

1.3

1.2

u/ml

6.5

16.0

4.52

370

1970

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

981

5310

2.09

81.36

1.3

1.2

iu/ml

30.3

38.5

0.64

295

1725

(3026493) Urate [Moles/volume] in Serum or Plasma

1407

9258

1.76

61.42

2.8

2.6

umol/l

4400.4

3942.5

0.15

1229

8121

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4078

36452

2.38

58.76

16.3

12.5

mg/l

19.3

24.3

22.83

3367

28198

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1147

7197

1.80

58.41

1.9

1.7

mg/l

1.1

1.2

0.59

899

5522

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1433

9711

1.70

54.95

2.3

2.0

u/l

171.8

239.4

2.70

1343

9094

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3261

27266

1.73

54.92

7.9

7.6

u/l

76.7

78.7

2.46

3087

25705

(3013826) Glucose [Moles/volume] in Serum or Plasma

2496

20028

1.56

44.49

5.1

4.7

mmol/l

6.7

6.8

1.28

2357

18699

(3037467) Urinalysis macro (dipstick) panel - Urine

2820

23425

1.55

41.69

4.7

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3190

27280

1.59

41.25

4.3

3.8

pmol/l

14.7

0.42

2940

24849

(3013115) Eosinophils [#/volume] in Blood

2247

17793

1.53

41.20

6.4

6.1

e9/l

0.2

0.76

1993

15588

(3037522) Nuclear Ab [Titer] in Serum

730

4428

1.78

39.88

1.4

1.3

titre

644.6

536.9

0.59

138

950

(3006315) Basophils [#/volume] in Blood

2176

17192

1.52

39.78

6.3

5.9

e9/l

0.0

0.06

1916

14812

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3726

33255

1.73

39.32

5.1

4.4

mu/l

2.0

2.4

1.17

3454

30427

(3019198) Lymphocytes [#/volume] in Blood

2219

17636

1.51

39.22

6.4

5.9

e9/l

2.0

1.9

0.89

1981

15488

(3001604) Monocytes [#/volume] in Blood

2164

17120

1.51

39.02

6.3

5.9

e9/l

0.6

0.50

1912

14744

(3031040) Bacteria [#/volume] in Urine by Automated count

2642

21823

1.52

38.53

4.8

3.8

e6/l

2842.0

1420.5

0.22

296

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3810

34278

1.76

38.29

6.5

5.4

mmol/mol

39.7

0.16

3573

31788

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1418

10302

1.55

37.71

3.0

2.5

u/l

53.5

59.0

3.20

1322

9520

(3023103) Potassium [Moles/volume] in Serum or Plasma

4125

38186

2.06

36.00

18.0

14.6

mmol/l

4.0

2.99

4043

37086

(3019550) Sodium [Moles/volume] in Serum or Plasma

4112

38034

2.03

35.80

17.8

14.5

mmol/l

139.9

139.8

3.92

4040

37023

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2013

15965

1.48

34.17

4.0

3.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2434

20095

1.46

33.21

9.0

9.8

e9/l

4.0

0.04

2170

17499

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2709

22916

1.46

31.99

3.1

2.7

—

(40761511) CBC panel - Blood by Automated count

4140

38617

2.00

31.58

14.7

11.8

—

(3018010) Neutrophils/100 leukocytes in Blood

2061

16586

1.45

31.50

6.3

6.0

56.5

57.2

2.03

1937

15554

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3934

36132

1.75

31.43

5.1

4.3

mmol/l

5.9

0.42

3647

33060

(3019069) Monocytes/100 leukocytes in Blood

2034

16363

1.45

30.95

6.6

6.4

8.5

8.7

1.96

1915

15380

(3002030) Lymphocytes/100 leukocytes in Blood

2086

16862

1.45

30.92

6.4

6.2

28.8

27.9

3.54

1947

15738

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1607

12374

1.47

30.75

3.7

3.1

ng/l

30.3

58.3

2.93

1093

8170

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1888

15028

1.44

30.14

6.4

6.2

mmol/l

1.2

0.30

1701

13634

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2052

16596

1.44

30.00

7.3

7.0

mmol/l

1.2

0.47

1758

13949

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2194

17971

1.43

29.88

6.0

6.8

umol/l

11.0

11.7

1.59

2083

17099

(3006504) Eosinophils/100 leukocytes in Blood

2018

16281

1.44

29.84

6.3

6.1

3.0

2.9

1.42

1885

15218

(3035350) Ketones [Presence] in Urine by Test strip

2025

16352

1.44

29.78

3.9

3.2

estimate

0.0

0.80

367

2997

(3008898) HLA-B27 [Presence]

210

901

2.40

29.65

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

706

4580

1.64

29.35

1.2

—

(3022096) Basophils/100 leukocytes in Blood

1961

15782

1.43

29.16

6.3

6.2

0.7

0.77

1833

14773

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1720

13521

1.44

29.04

2.1

1.9

pmol/l

99.5

95.9

2.17

905

7026

(3009261) Glucose [Presence] in Urine by Test strip

2043

16617

1.42

28.37

4.0

3.2

estimate

0.0

1.72

363

2955

(3042936) Bacteria identified in Isolate by Culture

710

4666

1.62

27.90

2.2

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1205

8902

1.48

27.87

3.0

2.9

ng/l

1043.7

1392.3

1.88

1001

7636

(3021601) Nitrite [Presence] in Urine by Test strip

2022

16459

1.42

27.73

5.2

4.4

estimate

0.0

0.73

387

3074

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1530

11864

1.44

27.38

3.9

3.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4023

37465

1.75

26.90

4.9

4.3

mmol/l

4.7

4.18

3787

34886

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1752

14005

1.41

26.13

2.5

2.2

nmol/l

77.8

77.3

0.29

1576

12684

(3032080) INR in Blood by Coagulation assay

1705

13567

1.42

26.09

9.2

8.6

inr

1.2

0.78

459

3941

(3015171) Extractable nuclear Ab [Units/volume] in Serum

240

1149

2.15

26.09

1.3

1.2

u/ml

0.2

1.4

2.45

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3894

36022

1.64

25.84

4.4

3.8

mmol/l

1.4

1.3

7.37

3629

33146

(3024561) Albumin [Mass/volume] in Serum or Plasma

1815

14628

1.41

25.69

4.9

5.2

g/l

36.3

35.6

7.21

1709

13651

(3007853) Bacteria identified in Skin by Aerobe culture

586

3750

1.65

25.46

1.9

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3996

37239

1.70

25.42

4.9

4.3

mmol/l

1.4

1.5

9.47

3748

34489

(3000475) Leukocytes [#/volume] in Synovial fluid

168

699

2.46

25.39

1.8

1.6

e6/l

8037.8

13920.1

1.71

126

496

(42870588) Differential panel, method unspecified - Blood

1494

11684

1.42

24.92

6.2

6.0

—

(3007461) Platelets [#/volume] in Blood

4343

41652

2.60

24.70

23.5

18.6

e9/l

251.3

250.8

0.23

4285

40513

(3022217) INR in Platelet poor plasma by Coagulation assay

628

4118

1.61

24.68

22.7

22.8

inr

1.3

0.05

631

(3024731) MCV [Entitic volume]

4344

41680

2.60

24.43

23.4

18.5

91.0

0.09

4313

41061

(3026361) Erythrocytes [#/volume] in Blood

4344

41684

2.59

24.35

23.5

18.6

e12/l

4.6

4.5

4.89

4278

40423

(3015736) pH of Urine

1576

12484

1.41

24.27

3.7

3.0

—

5.8

—

(3035941) MCH [Entitic mass]

4343

41675

2.58

24.25

23.4

18.5

30.4

30.3

0.84

4312

41054

(3010813) Leukocytes [#/volume] in Blood

4344

41690

2.59

24.23

23.5

18.6

e9/l

6.7

6.6

1.40

4276

40417

(3000963) Hemoglobin [Mass/volume] in Blood

4344

41696

2.58

24.11

23.6

18.7

g/l

137.9

136.8

5.89

4315

41073

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4060

38084

1.73

24.09

5.5

4.7

mmol/l

2.8

2.81

3799

35249

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4207

39902

1.95

23.83

11.9

9.8

u/l

28.3

27.2

2.81

4085

38481

(3013512) EKG study

1311

10131

1.42

22.98

4.1

3.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3824

35492

1.54

21.97

14.0

12.1

ml/min/173m2

81.1

81.9

1.62

3266

29138

(3044889) 12 lead EKG panel

2916

25833

1.37

21.20

4.1

3.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

341

1975

1.79

21.19

1.4

1.3

u/ml

203.3

198.9

0.04

317

1826

(40768804) Tissue Pathology biopsy report

1815

14950

1.36

21.16

2.1

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2833

25006

1.36

20.93

3.4

2.9

u/l

49.5

48.6

0.23

2642

23377

(40761535) Cells panel - Urine sediment

394

2404

1.70

20.36

4.1

3.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

986

7381

1.43

20.22

4.1

3.1

—

(3048689) Calprotectin [Mass/mass] in Stool

565

3778

1.57

20.18

2.0

2.3

ug/g

118.3

140.6

1.09

445

2998

(3030467) Casts [#/volume] in Urine by Automated count

1185

9186

1.39

19.83

3.6

3.0

e6/l

0.3

0.4

1.55

900

6758

(3018095) Leukocytes [#/volume] in Urine

1463

11758

1.36

19.54

4.3

3.4

e6/l

68.0

101.8

1.30

1060

8186

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1733

14299

1.35

19.48

3.2

2.7

ug/l

128.2

144.4

1.53

1608

13271

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

786

5677

1.47

19.41

1.6

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

1272

10055

1.37

18.69

3.8

3.0

e6/l

53.9

82.2

0.71

993

7590

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

860

6362

1.44

18.63

4.1

3.4

ng/l

196.3

648.6

2.01

636

4898

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

772

5597

1.46

18.62

3.2

2.6

e6/l

1.0

1.1

0.20

475

3064

(3026008) Bacteria identified in Urine by Culture

1165

9085

1.38

18.60

3.1

2.7

—

(3045414) Leukocytes [Presence] in Urine

257

1421

1.86

18.58

2.2

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

1342

10752

1.35

17.94

2.3

2.4

—

(36304419) Bacteria [Presence] in Urine

1144

8949

1.37

17.78

3.5

2.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

179

889

2.06

17.71

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

125

537

2.37

17.69

1.7

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

167

817

2.08

17.21

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

164

808

2.07

16.60

1.6

1.3

—

(3019150) Specific gravity of Urine by Refractometry

888

6732

1.40

16.52

4.4

3.5

kg/l

1.0

0.03

135

1020

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

355

2233

1.64

16.26

2.5

2.3

au/ml

24.0

23.7

0.02

154

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

573

4031

1.48

15.95

8.0

5.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1403

11478

1.32

15.84

3.1

3.7

mmol/l

2.4

0.45

1218

10136

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1050

8230

1.36

15.82

2.4

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1003

7806

1.37

15.81

2.4

2.1

mg/l

2.9

0.02

848

6651

(3000850) Epithelial cells [#/volume] in Urine

883

6759

1.38

15.37

2.8

2.5

e6/l

4.7

5.7

1.71

772

5922

(3000494) Fungus identified in Specimen by Culture

575

4078

1.47

15.33

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

986

7686

1.36

15.32

4.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1533

12744

1.31

15.30

4.0

3.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

687

5050

1.43

15.12

2.1

1.8

—

(40758558) Short blood count panel - Blood

1115

8878

1.34

15.03

6.3

7.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

913

7052

1.37

14.99

1.3

1.2

u/ml

1.6

2.2

0.75

235

1892

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

712

5280

1.41

14.90

3.5

2.8

e6/l

3.2

2.2

1.15

415

2758

(4010399)

357

2299

1.60

14.85

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1349

11087

1.31

14.44

4.1

mg/mmol

6.9

9.7

1.76

850

7101

(3047007) Chlamydophila sp Ab [Presence] in Serum

105

458

2.32

14.42

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

935

7309

1.35

14.11

1.6

1.5

nmol/l

20.8

20.5

0.20

788

6250

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

319

2031

1.61

13.91

1.4

1.3

au/ml

45.2

53.3

—

102

(3012516) Albumin [Mass/volume] in Urine

1283

10520

1.31

13.86

3.4

3.3

mg/l

546.9

332.1

0.76

807

6720

(3019309) Folate [Moles/volume] in Red Blood Cells

735

5552

1.39

13.72

1.7

nmol/l

1134.4

1130.3

0.04

563

4185

(3021589) Normoblasts [#/volume] in Blood

1842

15847

1.28

13.64

9.8

9.3

e9/l

0.0

0.24

1551

12949

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

386

2587

1.54

13.48

2.4

2.1

ug/l

6.0

9.4

3.20

340

2322

(3036481) Cortisol [Moles/volume] in Serum or Plasma

426

2922

1.51

13.34

2.1

2.3

nmol/l

353.4

376.6

1.41

390

2702

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

353

2327

1.56

13.27

4.1

4.2

ng/l

90.7

96.2

0.44

316

2038

(3025941) Bacteria identified in Stool by Culture

279

1743

1.64

13.13

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

176

966

1.86

13.08

1.6

1.8

—

(3018418) pH of Serum or Plasma

1192

9754

1.30

12.89

4.5

4.2

7.4

0.17

201

1967

(3013139) Helicobacter pylori Ag [Presence] in Stool

329

2151

1.57

12.82

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1061

8579

1.31

12.47

4.4

3.5

estimate

0.0

1.79

380

2925

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

479

3422

1.45

12.19

1.9

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

1330

11104

1.28

12.19

3.3

3.2

mmol/l

7.9

7.7

0.48

1126

9375

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1406

11834

1.27

12.03

3.1

3.3

u/l

33.5

37.0

0.69

1341

11259

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

101

469

2.18

12.01

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

236

1447

1.67

11.96

1.9

2.0

u/l

38.7

39.4

0.20

213

1301

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

100

465

2.18

11.86

1.2

1.1

au/ml

5.3

12.5

—

(3017732) Neutrophils [#/volume] in Blood

355

2405

1.52

11.78

2.4

3.1

e9/l

4.1

4.0

0.20

273

1924

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

309

2045

1.55

11.42

3.5

kpa

5.1

0.06

285

1898

(3017446) Testosterone [Moles/volume] in Serum or Plasma

399

2788

1.47

11.38

2.5

2.1

nmol/l

13.2

13.4

0.21

353

2511

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

476

3441

1.43

11.34

2.0

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

672

5148

1.36

11.33

2.7

2.5

umol/l

13.2

13.4

0.27

627

4830

(3044941) Cell count panel - Synovial fluid

462

2.15

11.25

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

295

1940

1.56

11.22

3.4

mmol/l

1.2

1.7

1.95

207

1447

(3007164) IgA [Mass/volume] in Serum or Plasma

809

6388

1.33

11.12

1.4

1.5

g/l

2.5

0.08

471

4012

(3023368) Bacteria identified in Blood by Culture

1085

8914

1.29

11.11

4.8

4.3

—

(3009343) pH of Capillary blood

304

2021

1.54

11.01

3.6

3.5

7.4

0.14

254

(3019225) pH of Specimen

463

3361

1.42

10.77

4.1

4.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1481

12679

1.25

10.67

5.2

4.6

ug/l

3.5

2.9

0.25

1351

11427

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

350

2.28

10.57

1.6

52.8

58.6

0.56

225

(3002385) Erythrocyte distribution width [Ratio]

3283

30678

1.27

10.49

18.4

15.8

13.7

0.42

3240

29994

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

132

711

1.88

10.47

1.3

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

209

1291

1.65

10.33

3.8

3.6

mmol/l

24.7

24.9

0.39

193

1196

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

164

951

1.75

10.23

1.8

1.7

g/l

0.2

0.43

156

905

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

267

1754

1.56

10.21

1.7

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

173

1020

1.72

10.18

1.7

1.8

—

(3026782) Osmolality of Urine

801

6397

1.31

10.06

3.0

2.6

mosm/kgh2o

553.7

554.9

0.05

681

5457

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

212

2.61

9.96

1.4

1.3

u/ml

1.9

1.0

0.31

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

168

990

1.72

9.92

1.7

1.6

g/l

1.2

0.28

160

943

(3004789) Transferrin [Mass/volume] in Serum or Plasma

618

4770

1.34

9.85

2.7

2.5

g/l

2.4

2.3

2.63

577

4458

(3022313) Gas panel - Capillary blood

234

1505

1.59

9.82

3.8

3.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

320

2208

1.48

9.73

1.7

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

125

679

1.87

9.69

2.7

2.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

112

591

1.92

9.50

1.9

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

750

5983

1.30

9.45

2.7

3.2

mmol/l

2.4

1.14

649

5272

(3049717) Cytology report of Urine Cyto stain

199

1245

1.63

9.38

2.5

2.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

865

1.75

9.29

1.1

u/ml

4.7

8.2

0.54

119

(3045424) Erythrocytes [Presence] in Urine

109

578

1.91

9.12

1.6

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

143

827

1.75

9.05

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

142

820

1.76

9.03

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

155

2.79

8.89

1.7

1.6

u/l

5.5

6.2

0.57

135

(3033658) Prothrombin time (PT) actual/Normal

1074

9024

1.25

8.81

4.0

91.8

90.8

0.70

1044

8836

(42529406) Shigella sp [Presence] in Stool by Culture

143

834

1.74

8.80

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

136

783

1.76

8.75

1.9

1.8

pmol/l

199.8

209.9

0.61

131

745

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

584

4551

1.33

8.67

5.2

4.3

31.4

32.0

0.67

412

3092

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

146

863

1.72

8.57

1.3

1.2

u/ml

8.5

7.3

0.09

144

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

377

2749

1.41

8.53

2.8

2.5

ml/min/173m2

69.3

66.3

0.89

170

1018

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

431

3215

1.38

8.52

2.7

2.3

u/l

33.3

53.9

0.78

370

2793

(3009542) Hematocrit [Volume Fraction] of Blood

3610

34363

1.26

8.46

16.4

13.7

40.5

40.1

1.24

2681

25628

(3022621) pH of Urine by Test strip

297

2081

1.46

8.37

2.9

2.8

—

(3022145) Colonoscopy Study observation

518

3987

1.34

8.36

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

232

1547

1.53

8.34

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

263

2.30

8.31

1.4

e6/l

33478.7

86468.1

0.89

181

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

144

856

1.70

8.29

1.4

1.2

u/ml

1.8

2.9

1.40

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

571

4466

1.32

8.24

2.8

2.6

22.7

23.4

0.67

489

3885

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

269

1861

1.47

8.10

1.9

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

239

1615

1.51

8.08

2.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

153

932

1.66

8.05

1.3

1.2

u/ml

8.8

34.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

495

3809

1.34

8.00

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

536

1.87

7.83

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

351

2.07

7.70

1.6

2.2

mg/l

19.6

23.7

0.33

(3016502) Oxygen saturation in Arterial blood

437

3320

1.35

7.69

8.1

9.0

95.8

95.9

0.03

428

3197

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

254

2.26

7.63

1.4

27.4

29.7

0.15

147

(3009445) Proteinase 3 Ab [Units/volume] in Serum

215

1439

1.52

7.62

1.8

1.6

u/ml

9.2

16.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

430

1.95

7.51

1.2

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

509

1.86

7.45

1.7

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

232

1587

1.49

7.41

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1175

10124

1.22

7.41

4.3

3.9

21.6

21.9

0.23

554

4787

(3024522) Salmonella sp identified in Specimen by Organism specific culture

426

1.94

7.37

1.2

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.33

7.24

1.1

—

(36660697) Celiac disease serology panel - Serum

346

2559

1.38

7.22

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

173

1119

1.57

7.17

2.0

2.4

ug/l

450.0

737.0

0.55

159

1062

(40768443) Skin Pathology biopsy report

222

1521

1.48

7.05

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

419

1.93

7.04

1.2

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

119

704

1.71

7.04

1.2

u/ml

1.5

4.3

0.59

(3027801) Oxygen [Partial pressure] in Arterial blood

477

3720

1.32

7.01

7.9

8.4

kpa

12.0

12.7

2.42

461

3564

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

477

3723

1.31

6.97

8.0

8.4

kpa

5.2

5.1

0.71

462

3568

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

115

677

1.72

6.93

1.3

1.2

u/ml

64.0

40.0

0.79

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1143

9880

1.21

6.90

1.7

1.6

mmol/l

1.4

0.69

950

8225

(3003396) Base excess in Arterial blood by calculation

476

3724

1.31

6.84

7.9

8.4

mmol/l

1.4

1.0

1.72

395

2935

(3000330) Specific gravity of Urine by Test strip

229

1589

1.47

6.83

3.6

3.1

—

(3019060) Gas panel - Arterial blood

282

2034

1.41

6.83

5.9

5.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

424

1.90

6.81

1.2

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

417

1.91

6.81

1.2

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

418

1.91

6.76

1.2

1.5

—

(3024263) Appearance of Synovial fluid

161

2.50

6.74

2.2

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

195

1315

1.50

6.71

2.4

2.0

ug/l

2.6

0.00

174

1200

(3000570) Elastase.pancreatic [Mass/mass] in Stool

141

885

1.61

6.66

1.6

1.4

ug/g

252.0

276.1

0.83

523

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

464

1.85

6.62

1.1

1.3

nmol/l

0.6

4.0

0.72

449

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

147

935

1.59

6.58

2.2

2.0

mg/l

10.7

11.6

0.69

139

880

(3017181) Myelocytes/100 leukocytes in Blood

380

2905

1.34

6.42

4.1

4.2

0.8

1.0

0.89

103

834

(4306422)

536

1.77

6.36

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

413

1.88

6.35

1.1

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

142

2.55

6.35

1.1

95.0

93.0

0.11

119

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

348

2633

1.35

6.31

2.8

2.7

ng/l

145.6

188.4

2.03

320

2376

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

465

1.82

6.28

1.2

1.3

nmol/l

0.1

0.3

—

(3025159) Blasts/100 leukocytes in Blood

343

2597

1.35

6.19

4.2

1.2

0.3

0.40

653

(3002179) Metamyelocytes/100 leukocytes in Blood

348

2642

1.34

6.17

3.8

4.0

0.9

0.6

0.44

605

(3020630) Protein [Mass/volume] in Serum or Plasma

341

2582

1.35

6.15

2.8

2.6

g/l

66.5

66.4

0.11

306

2390

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

529

1.75

6.07

1.1

123.2

116.1

1.36

485

(3002173) Hemoglobin [Mass/volume] in Arterial blood

398

3093

1.31

6.01

8.9

9.4

g/l

125.1

121.5

2.68

390

2978

(3009214) Lutropin [Units/volume] in Serum or Plasma

131

830

1.60

5.99

1.4

1.3

u/l

8.1

11.3

2.65

104

672

(3021440) Promyelocytes/100 leukocytes in Blood

360

2764

1.33

5.92

4.2

0.5

0.1

0.54

781

(3004588) Protein electrophoresis panel - Serum or Plasma

281

2077

1.38

5.92

2.4

2.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

367

2826

1.33

5.92

7.1

8.3

mmol/l

1.3

0.06

354

2738

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

405

1.84

5.77

1.2

1.3

nmol/l

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

677

5643

1.24

5.75

3.2

3.7

mmol/l

0.8

0.57

624

5314

(3003458) Phosphate [Moles/volume] in Serum or Plasma

541

4401

1.26

5.71

6.9

6.5

mmol/l

1.0

0.08

511

4135

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

833

7101

1.21

5.68

1.7

1.6

pmol/l

9039168.0

27672857.3

1.05

697

5959

(3041096) Erythrocytes [Presence] in Urine by Automated

1055

9200

1.19

5.63

3.4

3.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

221

2.14

5.62

1.1

—

(3011985) Renin [Units/volume] in Plasma

460

1.77

5.61

1.3

1.4

mu/l

70.3

58.8

0.30

407

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

500

4043

1.27

5.56

2.5

2.8

umol/l

6.6

8.9

2.73

443

3561

(3014007) Fractional oxyhemoglobin in Arterial blood

278

2074

1.36

5.54

8.7

10.6

94.1

94.2

0.08

278

2066

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

706

1.62

5.51

1.2

—

10.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

260

1929

1.37

5.38

8.8

7.8

mmol/l

25.0

24.5

1.71

247

1799

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

357

2783

1.31

5.29

2.1

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

559

1.68

5.28

1.2

u/ml

1.9

3.4

1.13

186

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

276

2074

1.35

5.27

8.8

10.4

1.4

1.3

0.56

276

2058

(3024928) Oxygen saturation in Venous blood

111

699

1.60

5.26

3.8

—

(3023520) Reticulocytes [#/volume] in Blood

340

2636

1.31

5.24

2.9

2.7

e9/l

70.2

70.7

0.10

265

1963

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

876

7558

1.20

5.22

3.3

2.9

ug/l

0.7

0.8

2.37

578

4833

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

396

3143

1.29

5.12

1.4

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

274

2074

1.34

5.00

8.8

10.5

0.6

0.7

0.42

274

2056

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.78

4.87

1.2

1.3

63.3

53.9

0.50

(4146454)

369

1.80

4.86

2.6

2.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

335

2620

1.30

4.86

2.7

g/l

10.0

10.6

2.32

302

2406

(3027945) Reticulocytes/100 erythrocytes in Blood

441

3576

1.26

4.80

2.7

2.6

1.8

0.08

389

3200

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

163

1139

1.45

4.79

1.8

1.6

titre

154.3

369.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.95

4.71

1.4

1.2

mg/l

359.1

100.8

0.42

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

287

1.89

4.68

1.6

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

628

5305

1.21

4.66

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

508

4199

1.24

4.66

7.5

7.9

mmol/l

104.2

104.7

1.56

497

4109

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

276

2115

1.33

4.65

3.2

3.4

pmol/l

4.6

4.5

0.77

243

1899

(3009015) Lactate [Moles/volume] in Synovial fluid

4.15

4.62

1.7

1.3

mmol/l

4.0

6.2

—

(3004616) Nuclear Ab [Presence] in Serum

420

1.73

4.61

1.4

1.3

—

(44790049)

392

1.75

4.54

1.4

1.6

—

(44790047)

392

1.75

4.54

1.4

1.6

—

(44790048)

392

1.75

4.54

1.4

1.6

—

(44806118)

392

1.75

4.54

1.4

1.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

131

887

1.49

4.54

4.6

4.5

mmol/l

3.9

0.17

125

824

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

119

790

1.52

4.53

1.2

1.3

mg/l

530.6

508.5

0.19

112

750

(3017143) Hepatitis C virus Ab [Presence] in Serum

462

3798

1.24

4.46

1.7

1.6

—

(3000492) Spirometry study

429

3500

1.25

4.43

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

203

1498

1.37

4.40

1.3

iu/l

28.1

33.8

1.75

185

1295

(3003338) MCHC [Mass/volume]

3312

31827

1.16

4.34

20.3

16.1

g/l

333.1

332.7

1.15

3299

31609

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

451

1.67

4.33

7.7

6.7

mg/l

11.5

11.2

0.23

420

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

437

1.68

4.28

1.2

1.3

pmol/l

234.5

353.7

0.94

335

(3000991) Gas panel - Venous blood

345

2757

1.27

4.26

9.1

9.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.70

4.24

1.6

1.2

g/l

38.5

38.9

0.04

(3002256) Pathology report gross observation

574

4851

1.21

4.24

1.4

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

199

2.02

4.21

1.1

1.2

ratio

1.1

0.78

(3036489) Thrombin time

183

1338

1.38

4.21

1.7

2.0

20.7

21.7

2.04

146

1185

(3016018) Differential panel - Cerebral spinal fluid

364

1.74

4.21

1.1

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

146

2.20

4.20

1.7

1.3

nmol/l

144.4

135.3

0.70

146

(3044290) Cell count panel - Cerebral spinal fluid

103

675

1.54

4.19

1.1

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

4.08

4.16

1.5

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

207

1.99

4.15

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

307

1.80

4.13

2.4

2.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

124

848

1.48

4.12

1.5

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

121

824

1.48

4.11

1.5

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

314

2492

1.28

4.11

2.1

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

135

942

1.45

4.06

3.1

3.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.52

4.04

1.2

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

156

1119

1.41

4.03

2.6

2.2

g/l

2.9

3.1

1.38

118

911

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

295

1.81

4.02

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

295

1.81

4.02

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

295

1.81

4.02

1.5

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

171

1247

1.39

4.01

2.0

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

223

1700

1.33

3.94

3.3

2.7

e6/l

0.2

0.3

0.76

210

1644

(3024980) IgG subclass 4 [Mass/volume] in Serum

535

1.58

3.89

1.9

1.6

g/l

0.6

0.9

1.94

411

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

462

3855

1.22

3.89

4.4

4.7

u/l

239.4

242.3

0.18

433

3682

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

373

1.70

3.89

1.5

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

206

1556

1.34

3.88

4.7

4.6

mmol/l

24.8

24.0

2.46

178

1422

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

352

1.71

3.83

1.6

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

361

2943

1.25

3.78

4.9

4.0

kpa

5.9

5.8

0.92

348

2856

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

183

1365

1.36

3.76

2.1

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

284

2254

1.28

3.74

1.1

1.2

iu/ml

76.1

149.5

4.63

870

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

478

1.60

3.73

1.1

u/ml

4.8

3.4

0.24

239

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

171

1265

1.37

3.70

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

186

1396

1.35

3.68

3.5

2.9

0.6

0.68

177

1345

(44813793)

196

1.95

3.66

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

270

0.33

3.66

16.4

12.0

nmol/l

539.7

866.7

—

257

(4015189)

2.61

3.63

2.4

1.6

—

(3020891) Body temperature

162

1195

1.37

3.58

5.0

4.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

429

3585

1.22

3.57

3.2

3.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1189

1.37

3.54

2.5

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1189

1.37

3.54

2.5

2.1

g/l

3.8

3.9

0.12

116

888

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1190

1.37

3.52

2.5

2.1

g/l

7.3

7.4

0.24

122

928

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

186

1.94

3.47

1.4

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

401

1.63

3.47

1.1

104.9

97.5

1.29

376

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

310

1.72

3.45

2.3

2.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

610

5282

1.18

3.44

2.3

2.2

29.6

29.9

0.50

591

5129

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

441

1.60

3.44

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

187

1.93

3.42

1.4

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

522

1.54

3.39

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

101

2.28

3.35

1.2

g/l

0.3

0.76

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

225

1.83

3.32

1.2

1.1

mg/l

36.1

41.1

0.37

184

(3002032) Base excess in Venous blood by calculation

355

2940

1.23

3.25

4.9

4.1

mmol/l

2.3

1.8

1.71

300

2388

(3035320) C reactive protein [Mass/volume] in Body fluid

213

1.84

3.21

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

199

1.87

3.20

1.0

1.1

iu/ml

3.8

9.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

242

1924

1.27

3.19

4.0

3.5

g/l

132.0

129.2

1.05

232

1871

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

117

2.14

3.15

1.3

1.1

ng/l

98.0

329.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

131

2.07

3.11

1.3

1.4

6.8

3.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

100

697

1.44

3.11

1.2

1.5

e6/l

1275.2

1150.1

0.04

544

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

120

865

1.40

3.10

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

406

1.58

3.09

1.5

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

100

698

1.44

3.09

1.1

1.4

e6/l

17.9

17.5

0.01

510

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

148

1105

1.35

3.08

2.5

2.7

—

(3014271) Vancomycin [Susceptibility]

125

2.09

3.07

3.6

2.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

129

944

1.38

3.05

2.8

2.0

g/l

38.1

37.6

0.40

110

837

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

330

1.64

3.03

1.1

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

134

988

1.37

3.03

1.6

iu/ml

0.0

1.1

0.73

198

(3006442) Creatine [Moles/volume] in Serum or Plasma

255

1.73

3.00

1.6

1.4

umol/l

65.7

68.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

305

2509

1.23

3.00

1.4

1.5

—

(4027681)

168

1.91

2.99

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

605

1.46

2.95

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

549

1.48

2.92

1.2

u/ml

2.8

4.0

1.15

239

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

521

4520

1.17

2.89

1.7

1.4

0.03

448

4015

(4035726)

298

3594

0.82

2.88

1.3

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

255

2067

1.25

2.88

1.6

1.9

g/l

1.1

1.4

3.23

228

1895

(3015235) Bicarbonate [Moles/volume] in Capillary blood

109

784

1.40

2.88

2.8

3.2

mmol/l

24.1

24.8

1.43

677

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

276

0.36

2.86

15.4

17.0

nmol/l

1033.0

1479.2

—

267

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

171

1.88

2.85

1.3

1.8

u/field

1.3

3.4

1.23

123

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

185

1445

1.29

2.84

2.0

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

687

1.42

2.80

1.2

1.3

mmol/l

3.8

0.01

642

(3023511) Choriogonadotropin [Units/volume] in Urine

378

1.57

2.77

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

293

1.65

2.74

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

139

1049

1.34

2.74

1.5

—

(3036603) Volume of Urine

233

1.72

2.71

1.8

1.7

1311.0

1814.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

461

1.50

2.69

1.3

u/l

25.4

34.0

1.18

376

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

227

1832

1.25

2.68

8.7

10.6

mmol/l

24.7

24.2

1.76

213

1735

(3024354) Oxygen [Partial pressure] in Venous blood

284

2349

1.22

2.68

3.7

3.2

kpa

4.9

4.7

0.95

271

2277

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

669

1.41

2.66

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

184

1.80

2.60

1.1

nmol/l

0.1

15.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

124

929

1.34

2.58

3.1

3.2

ratio

4.8

2.2

0.31

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

7.15

2.55

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.73

2.54

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

323

1.59

2.54

1.8

1.3

g/l

6.1

6.9

1.11

225

(3024139) IgG subclass 3 [Mass/volume] in Serum

323

1.59

2.54

1.8

1.3

g/l

0.4

1.23

228

(3028192) IgG subclass 2 [Mass/volume] in Serum

324

1.58

2.51

1.8

1.3

g/l

2.7

3.0

0.60

229

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

146

1127

1.31

2.49

1.9

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

122

918

1.34

2.48

3.0

2.0

g/l

0.0

0.39

115

850

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

1119

1.31

2.47

2.7

2.1

g/l

9.9

10.3

0.47

119

972

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

135

1032

1.32

2.47

2.8

2.2

g/l

0.8

0.9

0.10

119

902

(3024891) Influenza virus A+B Ag [Presence] in Specimen

119

895

1.34

2.44

1.2

1.1

—

(4062490)

319

1.57

2.43

2.0

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

160

1.82

2.39

1.0

1.1

u/l

1.0

1.1

1.83

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.50

2.35

1.1

1.2

umol/24h

0.6

0.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

123

937

1.32

2.32

1.4

1.3

miu/ml

241.1

230.6

0.12

429

(3037756) Immunofixation for Serum or Plasma

628

1.39

2.32

1.9

1.7

—

(4268621)

381

1.50

2.27

2.2

2.3

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.48

2.27

2.0

1.4

mg/l

1.4

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.16

2.24

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.41

2.19

1.8

1.9

ng/l

105.2

156.4

0.60

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

124

955

1.31

2.19

3.2

mg/l

33.7

50.5

1.06

110

757

(3034860) Kappa light chains.free [Mass/volume] in Serum

124

955

1.31

2.19

3.2

mg/l

37.1

59.2

2.28

111

753

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

181

1463

1.25

2.17

1.8

g/l

1.5

0.02

153

1274

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

136

1.84

2.17

1.6

1.9

—

(1002224) Polysomnography panel

207

1701

1.23

2.14

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

274

1.57

2.14

1.2

—

(3034426) Prothrombin time (PT)

130

1.85

2.12

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

112

855

1.32

2.11

3.1

2.0

g/l

0.0

0.00

106

798

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

259

1.59

2.11

1.3

1.2

u/ml

2.4

3.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

624

1.37

2.08

1.3

—

(4094501)

136

1069

1.28

2.07

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.91

2.07

1.3

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.98

2.05

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.98

2.05

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

184

1.69

2.04

1.1

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

147

1171

1.26

2.02

1.9

2.1

98.4

90.7

4.25

138

1098

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

131

1030

1.28

2.00

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.96

2.00

1.6

1.5

ug/l

9.1

8.7

0.20

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

223

1862

1.21

1.99

11.3

11.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

112

864

1.30

1.98

3.1

2.0

g/l

0.0

0.00

106

799

(3020650) Glucose [Presence] in Urine

105

1.91

1.95

1.7

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

149

1.75

1.94

2.2

2.1

136.5

154.6

0.54

141

(3025315) Body weight

2.73

1.93

4.6

4.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

172

1.69

1.92

1.2

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

582

1.36

1.92

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

591

1.36

1.91

1.6

1.3

u/l

15.5

29.6

2.05

513

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1.56

1.89

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1.56

1.89

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

584

1.36

1.88

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

504

4509

1.13

1.88

1.7

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

324

1.49

1.88

1.4

1.3

nmol/l

1.6

1.4

0.60

286

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.31

1.87

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

333

1.48

1.86

2.0

3.7

57.3

0.00

221

(3025018) Bordetella pertussis Ab [Titer] in Serum

182

1.65

1.84

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.98

1.84

1.3

1.1

—

(21494755) Public health laboratory ask at order entry panel

365

4151

0.87

1.84

1.4

—

(3045716) Anion gap in Serum or Plasma

137

1.76

1.83

6.3

2.7

mmol/l

7.6

9.7

1.51

106

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

310

1.49

1.82

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

718

1.32

1.81

2.6

3.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

254

1.54

1.81

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

259

2214

1.18

1.81

1.8

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

101

1.88

1.80

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.06

1.80

1.0

1.1

u/ml

1.1

2.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

3.05

1.80

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

328

1.47

1.78

1.2

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

471

1.39

1.77

1.2

mmol/l

7.4

0.01

366

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

177

1.64

1.75

1.2

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

661

1.32

1.75

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

661

1.32

1.75

1.3

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

3.34

1.74

1.0

1.1

mmol/l

9.3

8.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

627

1.33

1.74

1.7

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.74

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

114

900

1.27

1.73

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

377

3329

1.14

1.73

2.3

g/l

0.2

0.52

359

3119

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

584

5301

1.12

1.72

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

465

1.38

1.72

1.6

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

1.76

1.71

2.4

2.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

282

1.49

1.71

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

407

1.41

1.70

2.7

2.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.95

1.69

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

251

1.52

1.67

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.38

1.67

1.2

1.1

—

(4034850)

132

1066

1.25

1.67

9.9

8.0

—

(3037121) Protein [Mass/volume] in Urine

141

1148

1.24

1.66

3.1

3.3

g/l

0.3

0.4

0.48

515

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

268

1.50

1.65

2.0

1.7

mg/l

3.2

4.0

1.29

257

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.89

1.65

1.5

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.93

1.64

1.3

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

112

1.79

1.64

1.5

1.6

pmol/l

15.1

16.6

0.46

(4024509)

318

1.45

1.64

1.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

150

1.67

1.63

1.2

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

150

1.67

1.63

1.2

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

360

3185

1.14

1.62

8.5

8.2

mmol/l

9.7

9.8

0.05

346

3045

(3017817) Protein [Mass] in Urine collected for unspecified duration

294

1.47

1.62

3.3

2.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

126

1017

1.25

1.61

2.1

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

254

1.50

1.60

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

254

1.50

1.60

1.1

—

(4281824)

425

0.63

1.59

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.95

1.59

1.0

—

(3011648) Oxygen content in Venous blood

288

1.46

1.57

2.3

2.6

11.6

11.2

0.27

288

(3042631) Mycobacterium sp identified in Specimen

474

1.36

1.56

2.4

2.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

264

1.48

1.55

1.6

2.0

u/field

1.7

2.4

0.23

110

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.89

1.54

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

169

1416

1.20

1.52

1.7

mg/l

3.1

4.0

0.80

139

1001

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

705

1.28

1.49

3.1

3.6

57.8

57.5

0.09

705

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

661

1.29

1.49

2.3

3.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

131

1.68

1.49

2.6

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.07

1.49

9.1

11.5

mmol/l

4.8

5.8

0.74

(3011288) Drugs identified in Urine by Screen method

639

1.29

1.43

1.4

2.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.79

1.42

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

535

1.31

1.41

1.1

u/ml

5.3

4.4

0.16

241

(40768446) Kidney Pathology biopsy report

157

1.60

1.40

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

372

1.38

1.39

1.1

—

3.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

130

1073

1.22

1.39

2.3

2.4

183.9

195.4

0.78

117

1023

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

589

1.30

1.39

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.08

1.38

1.1

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.94

1.38

3.5

5.2

—

(3017704) Immunofixation for Urine

166

1.57

1.37

1.9

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

600

1.29

1.36

1.1

u/ml

0.9

1.2

0.32

217

(3037556) Urate [Mass/volume] in Serum or Plasma

1.76

1.34

1.2

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

183

1.53

1.34

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

183

1.53

1.34

1.4

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

183

1.53

1.34

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

183

1.53

1.34

1.4

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

317

1.39

1.30

1.2

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

561

1.29

1.28

1.2

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

517

1.30

1.28

1.1

u/ml

3.7

1.7

0.40

194

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.78

1.28

1.4

1.6

umol/24h

232.0

391.8

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

22.1

21.7

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

1.1

8.0

8.4

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

39.7

37.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

172

1472

1.18

1.26

4.7

3.4

mmol/l

25.7

25.1

1.37

165

1422

(3008757) Leukocyte morphology finding [Identifier] in Blood

362

1.36

1.26

3.0

4.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

295

1.39

1.24

1.5

1.2

—

(3028433) Virus identified in Specimen by Culture

123

1.63

1.23

1.1

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

315

2823

1.12

1.22

3.4

3.8

mmol/l

1.2

0.05

268

2482

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

196

1.48

1.21

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

575

1.27

1.21

2.5

3.5

2.2

1.5

0.52

450

(40767503) Oxygen content in Capillary blood by calculation

692

1.25

1.20

2.0

2.4

16.5

16.4

0.09

345

(3027456) Digoxin [Moles/volume] in Serum or Plasma

515

1.29

1.18

2.6

3.0

nmol/l

0.8

0.04

384

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

489

1.29

1.18

1.6

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

498

1.29

1.17

1.1

u/ml

4.6

2.4

0.39

107

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

126

0.48

1.16

1.0

2.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.00

1.16

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.00

1.16

1.4

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.05

1.15

1.0

1.1

—

(4211845)

158

1.52

1.14

3.8

3.0

—

(40768806) Pleura Pathology biopsy report

391

0.69

1.14

1.9

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

379

0.68

1.13

1.7

1.5

—

(3044927) Protein electrophoresis panel - Urine

292

1.37

1.13

1.3

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.75

1.12

1.0

1.1

u/ml

59.0

57.8

0.02

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.34

1.12

1.0

1.4

umol/24h

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.90

1.12

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

728

1.23

1.09

2.2

1.8

nmol/l

0.9

0.8

0.35

610

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

495

1.28

1.09

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.38

1.09

1.4

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.38

1.09

1.6

2.0

umol/l

42.0

39.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

105

874

1.21

1.09

2.1

2.4

ug/min

184.5

95.7

0.62

545

(3000093) Morphology [Interpretation] in Blood Narrative

286

1.37

1.08

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

119

1003

1.19

1.08

8.9

7.2

mmol/l

1.4

1.3

0.20

111

881

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

120

1.59

1.08

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

211

1.42

1.05

1.3

1.5

—

(3006462) Nitrate [Presence] in Urine

145

1.52

1.05

4.0

3.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.12

1.05

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.12

1.05

1.7

3.0

u/field

0.3

0.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.12

1.05

1.1

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

129

1.55

1.05

5.8

1.4

umol/l

126.2

98.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

760

1.21

1.04

2.9

2.1

u/l

6649.0

3267.0

0.43

307

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

297

1.35

1.04

1.1

1.0

mg/l

284.6

284.4

0.01

274

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.96

1.03

1.3

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

252

0.63

1.03

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.06

1.02

2.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.92

1.02

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

369

0.70

1.01

1.6

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

709

1.22

1.00

2.0

2.1

g/l

133.4

130.5

0.46

505

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.88

1.00

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.84

0.98

1.8

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

447

0.74

0.98

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

481

0.75

0.97

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

366

0.71

0.97

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

446

0.74

0.96

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

165

1.46

0.96

1.4

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

388

0.72

0.96

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

407

1.28

0.96

1.1

u/ml

5.3

2.9

0.36

152

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

445

0.74

0.95

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

199

1.41

0.95

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

605

1.23

0.94

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

578

1.23

0.94

1.1

iu/ml

8.4

1098.7

0.55

123

(3021901) Oxygen saturation in Capillary blood

569

1.23

0.94

2.2

2.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

444

0.74

0.94

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

392

1.28

0.92

1.2

u/l

47.4

64.3

1.95

257

(3001729) Color of Synovial fluid

2.14

0.91

1.0

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

116

994

1.17

0.91

1.6

1.7

mu/l

284.2

321.5

0.95

106

907

(3028626) Oxygen [Partial pressure] in Capillary blood

691

1.20

0.90

2.3

2.9

kpa

8.4

8.2

0.69

629

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.69

0.88

1.7

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.79

0.87

1.1

1.6

—

194.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

1.53

0.87

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

103

1.56

0.87

1.1

1.5

—

(40768800) Prostate Pathology biopsy report

786

1.19

0.87

1.2

—

(3020491) Glucose [Moles/volume] in Blood

255

1.34

0.86

2.0

mmol/l

7.2

6.6

0.69

170

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

750

1.19

0.86

1.6

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

238

1.35

0.85

1.0

ng/l

834.0

714.9

0.61

178

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

151

1328

1.14

0.85

7.9

5.9

1.7

1.6

0.13

146

1237

(3047189) Immunofixation for 24 hour Urine

153

1.44

0.85

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

204

1.37

0.85

1.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

798

1.18

0.84

4.7

6.2

iu/ml

602.3

2482.7

0.49

118

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.78

0.84

1.1

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

203

0.64

0.84

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

239

1.34

0.84

1.0

ng/l

308.5

337.3

0.24

182

(40768793) Breast Pathology biopsy report

874

0.83

0.82

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.69

0.82

1.7

2.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.61

0.81

1.1

1.2

pmol/l

371.2

288.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

137

1203

1.14

0.80

1.7

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

241

1.33

0.80

1.0

ng/l

40.0

45.2

0.27

180

(3034274) Bile acid [Moles/volume] in Serum --fasting

250

1.32

0.80

1.7

1.9

umol/l

7.7

9.1

0.18

185

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

729

1.18

0.79

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate

164

1.40

0.79

1.3

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

151

0.60

0.78

1.2

2.6

nmol/l

159.4

144.7

—

130

(3048879) Bone marrow aspiration report

1.56

0.78

1.6

2.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

199

1.36

0.78

1.1

1.0

u/ml

0.4

2.5

0.73

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.50

0.77

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

234

1.33

0.77

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

349

1.26

0.77

1.3

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.76

0.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

2.08

0.74

1.0

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.67

0.74

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

280

1.29

0.74

1.7

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

1307

1.13

0.73

8.1

6.0

0.9

0.01

141

1220

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.84

0.73

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

125

1.44

0.72

2.2

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

202

1.34

0.72

3.0

2.9

35.8

37.7

—

(3052592) Norovirus Ag [Presence] in Stool

1.61

0.72

1.0

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

310

0.74

0.71

1.1

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

444

1.22

0.70

1.1

1.0

u/ml

3.6

2.2

0.25

160

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

582

1.19

0.70

1.5

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

143

1.40

0.70

1.5

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

143

1.40

0.70

1.5

2.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

205

0.68

0.69

15.9

10.5

mmol/l

0.6

0.10

179

(3051593) INR in Capillary blood by Coagulation assay

143

0.63

0.69

1.1

10.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

455

1.21

0.68

1.6

1.4

nmol/l

0.4

0.3

0.69

330

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.85

0.68

2.2

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.67

0.68

1.0

—

(1616796) Gas panel - Central venous blood

732

1.16

0.68

3.2

3.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

144

1.39

0.67

1.5

2.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

167

1848

0.90

0.67

3.1

3.8

u/ml

31.1

55.3

2.06

158

1786

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

832

0.85

0.67

1.7

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.63

0.66

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.79

0.66

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.57

0.65

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.48

0.64

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.72

0.64

1.0

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

198

1.31

0.64

1.0

u/ml

0.6

0.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

450

1.20

0.64

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

216

1.30

0.63

2.1

1.6

u/ml

42.2

19.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

116

1029

1.13

0.63

1.2

titre

64.4

189.7

—

(3045788) Cell count panel - Pleural fluid

325

0.77

0.62

1.6

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

683

1.16

0.62

1.7

1.5

u/ml

97.4

123.1

1.13

135

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.63

0.62

1.4

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

1.33

0.61

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.67

0.61

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.46

0.61

1.1

1.3

89.4

85.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.60

0.0

1.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

165

1.33

0.60

1.3

1.5

—

1009425.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

9.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

197

0.71

0.58

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.58

1.4

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

391

1.20

0.58

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.72

0.57

1.2

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

184

1.31

0.57

1.3

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

820

1.14

0.57

4.1

3.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.48

0.57

1.1

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.46

0.56

2.1

1.7

pmol/l

99.8

34.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.42

0.54

1.2

1.1

90.0

87.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

222

1.26

0.53

1.2

u/l

103.4

81.0

0.44

189

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

249

1.25

0.53

2.5

2.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.52

0.52

2.1

1.5

ug/l

0.3

0.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

205

1.27

0.52

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.43

0.52

1.3

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

406

1.18

0.51

1.6

2.9

—

(3011412) CD3 cells [#/volume] in Blood

342

1.20

0.51

2.4

e9/l

0.9

1.1

1.15

204

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

242

1.24

0.50

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

215

1.26

0.50

1.2

u/l

17.2

18.1

0.07

177

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.47

0.50

1.5

1.9

ug/l

2.3

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.47

0.50

7.4

7.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.39

0.50

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.46

0.50

2.0

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.46

0.50

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.46

0.50

2.3

2.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

529

1.16

0.49

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

362

1.19

0.49

1.1

1.0

u/ml

0.6

0.3

0.17

(37021550) Renin [Units/volume] in Plasma --upright

1.45

0.48

1.1

1.3

mu/l

41.6

60.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.41

0.46

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.41

0.46

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.41

0.46

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.46

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.41

0.46

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

617

1.14

0.46

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

182

1.27

0.46

1.0

u/ml

0.2

3.3

—

(3045142) Bone marrow Pathology biopsy report

440

0.84

0.46

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

547

0.86

0.46

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

119

0.67

0.45

1.0

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

120

0.67

0.45

1.0

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

138

1.31

0.45

1.2

1.4

umol/l

37.1

29.9

0.90

132

(3016879) Cocaine [Presence] in Urine

105

951

1.11

0.45

1.4

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

432

1.16

0.44

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

140

0.71

0.43

2.8

2.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

393

0.84

0.42

2.3

2.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

284

0.81

0.42

1.1

—

(3019174) dRVVT (LA screen)

1.56

0.42

1.2

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.56

0.42

1.0

1.1

u/l

6.2

18.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.56

0.42

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.43

0.41

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.43

0.41

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

239

0.79

0.41

6.1

6.5

—

(3042517) Benzodiazepines panel - Urine

0.00

0.41

0.0

2.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

12.5

—

(3012501) Base excess in Blood by calculation

747

1.11

0.41

3.7

4.2

mmol/l

2.6

0.00

512

(3009466) Valproate [Moles/volume] in Serum or Plasma

519

0.87

0.40

4.5

5.4

umol/l

358.6

375.6

0.31

447

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

333

1.17

0.40

1.6

1.3

pmol/l

787.9

64.7

0.49

102

(3051611) Lipemic interference index of Serum or Plasma

333

1.17

0.40

3.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

511

1.14

0.40

1.1

g/l

1.5

0.08

462

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.36

0.40

1.1

umol/l

16.9

17.3

0.15

(3004775) Volume in Urine collected for unspecified duration

306

1.18

0.39

2.3

2.2

672.5

652.4

0.09

205

(3001893) Eosinophils/100 leukocytes in Pleural fluid

101

0.69

0.39

1.3

1.5

1.4

2.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

346

0.84

0.39

1.4

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

106

1.32

0.39

6.6

8.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

752

1.11

0.37

2.6

3.1

umol/l

34.3

37.0

0.53

658

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

0.71

0.37

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

322

0.84

0.37

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

365

0.85

0.37

1.6

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

355

1.16

0.37

1.5

g/l

0.9

1.0

0.75

355

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

253

1.19

0.36

2.2

2.7

e6/l

990.4

615.3

1.09

110

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.36

0.36

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

272

1.18

0.36

2.4

2.0

17.5

14.7

0.55

107

(3044007) Cell count panel - Peritoneal fluid

122

0.74

0.35

3.7

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.35

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

111

1027

1.08

0.34

2.7

3.0

mg/l

1.5

0.29

952

(1175426) CD3 cells/100 lymphocytes in Blood

274

1.17

0.33

2.5

2.0

71.7

72.0

0.04

266

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

109

1.29

0.33

1.6

1.7

—

(3003694) ABO and Rh group [Type] in Blood

1030

10082

1.03

0.33

1.4

—

(44806420)

0.68

0.33

2.5

2.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

413

0.87

0.32

1.4

1.5

e6/l

6138.4

1997.3

0.42

287

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

381

0.87

0.32

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

125

1165

1.08

0.32

3.3

3.0

u/ml

0.3

0.05

656

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

146

1.23

0.32

1.5

nmol/l

1.2

6.2

1.04

119

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

132

0.76

0.32

1.7

1.6

mmol/l

8.0

8.5

—

(3029075) Extractable nuclear Ab panel - Serum

101

1.29

0.31

1.0

—

(1761868) Lipid panel - Serum or Plasma

1492

14686

1.02

0.31

2.9

2.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

618

1.10

0.31

2.4

2.8

u/ml

711.8

1608.0

—

(3035933) Granulocytes/100 leukocytes in Blood

1.29

0.30

4.0

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

106

987

1.08

0.29

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

288

1.15

0.29

1.3

1.1

titre

300.0

160.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

288

1.15

0.29

1.3

1.1

—

233.3

—

(40761536) Microorganisms panel - Urine sediment

304

2924

1.04

0.28

4.0

3.5

—

(3027008) Opiates [Presence] in Urine

111

1038

1.07

0.28

1.4

1.9

—

(3028300) Cannabinoids [Presence] in Urine

111

1040

1.07

0.27

1.4

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.21

0.26

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

205

2144

0.95

0.26

1.8

1.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.23

0.25

2.1

2.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

266

0.86

0.24

1.1

—

(3042733) HLA Ab [Presence] in Serum

142

1.20

0.24

6.4

4.9

—

(3000034) Microalbumin [Mass/volume] in Urine

340

1.12

0.24

2.3

3.0

mg/l

17.0

44.8

0.93

255

(3051651) Icteric interference index of Serum or Plasma

223

0.85

0.24

3.3

3.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.17

0.24

1.0

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

1.28

0.24

2.6

2.1

e6/l

102.0

470.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

265

0.87

0.24

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

124

1.21

0.24

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

374

3853

0.97

0.23

3.3

4.5

ug/l

6.9

29.9

3.07

296

3132

(3028679) Herpes simplex virus Ab [Presence] in Serum

171

1.17

0.23

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

190

1.16

0.23

2.0

2.6

110.0

93.5

1.58

181

(3027035) Albumin [Mass/time] in 24 hour Urine

1.28

0.23

1.4

—

222.2

—

(3000285) Sodium [Moles/volume] in Blood

1.28

0.23

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

162

1.17

0.22

2.2

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.25

0.22

1.0

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

153

1.18

0.22

2.7

3.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

116

1.21

0.22

2.7

2.2

5.4

10.9

1.62

108

(3000764) Benzodiazepines [Presence] in Urine

109

1031

1.06

0.21

1.4

2.0

—

(40768795) Lymph node Pathology biopsy report

430

0.91

0.21

1.4

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.19

0.21

1.4

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.19

0.21

1.6

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

7.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

769

1.07

0.21

1.4

2.0

—

(4133840)

104

0.77

0.21

1.1

1.2

—

(44806071)

1.16

0.21

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

615

1.07

0.20

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.4

—

2.5

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.4

—

0.9

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.4

—

2.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.4

—

2.9

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.4

—

2.7

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.4

—

5.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

307

1.11

0.20

3.3

3.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

279

1.11

0.19

1.1

1.3

mmol/l

9.7

12.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.24

0.18

2.0

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

380

3890

0.97

0.17

1.9

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

362

0.91

0.17

1.5

1.4

e6/l

15652.4

56739.2

1.50

197

(3041806) Other cells [#/volume] in Blood by Manual count

1.15

0.17

2.1

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.15

0.17

1.7

2.3

umol/l

9.8

18.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.11

0.17

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

120

1.17

0.16

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.78

0.15

1.3

2.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

130

1.15

0.15

1.1

1.5

—

(3000012) Reticulocyte production index

188

1.12

0.14

1.3

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

244

0.90

0.14

1.5

1.6

u/l

7.9

5.4

—

110

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

919

1.05

0.14

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

841

1.05

0.14

1.7

1.9

iu/l

124.3

4.9

0.49

322

(3004451) EKG impression Narrative

160

0.87

0.14

1.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

103

1.17

0.13

1.6

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

103

1.17

0.13

1.6

2.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

334

1.08

0.13

1.1

—

(3010421) pH of Blood

872

1.04

0.13

3.6

4.1

7.4

0.07

736

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.17

0.13

7.3

8.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

374

1.07

0.13

2.6

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

148

0.88

0.12

1.0

—

(3035880) pH of Pleural fluid

181

1.11

0.12

1.2

1.3

—

(40768441) Liver Pathology biopsy report

307

1.08

0.12

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

278

1.08

0.12

1.8

1.6

—

(21494434) Karyotype in Bone marrow

323

0.93

0.11

1.1

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

700

1.04

0.11

3.0

2.7

mmol/l

1.5

1.6

0.41

677

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

720

1.04

0.11

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.16

0.11

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

113

1095

1.03

0.10

2.7

2.6

g/l

3.6

3.7

0.34

106

1044

(3003181) Sodium [Moles/volume] in Urine

534

1.05

0.10

1.2

1.3

mmol/l

58.8

60.7

0.17

414

(3044242) Glucose [Moles/volume] in Arterial blood

173

1.10

0.10

1.5

2.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

290

0.93

0.10

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

125

1.12

0.10

1.1

—

(3017569) Oxygen content in Arterial blood

164

1.10

0.09

1.5

2.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

262

2575

1.02

0.09

1.5

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

116

1.12

0.09

2.8

2.1

32.5

28.6

0.44

109

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.13

0.09

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

126

1.11

0.09

1.4

1.1

miu/ml

1877.0

1541.1

0.32

126

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

237

0.93

0.09

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

117

1201

0.97

0.09

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

331

1.06

0.08

1.2

1.4

mosm/kgh2o

285.0

282.0

0.40

275

(3027944) Amphetamines [Presence] in Urine

105

1022

1.03

0.08

1.4

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.14

0.08

1.1

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.14

0.08

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.08

0.08

1.0

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

195

1.08

0.08

29.2

27.3

ug/l

97.3

115.0

1.08

162

(3051101) Glucose [Moles/volume] in Cord blood

1.03

0.07

6.4

7.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.12

0.07

1.6

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.08

0.07

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.04

0.07

1.6

3.2

u/l

126.8

2598.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.06

0.07

1.6

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

413

1.04

0.06

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

177

1.07

0.06

41.9

34.9

ug/l

7.4

7.3

0.10

162

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

132

1345

0.98

0.06

3.1

3.9

u/ml

35.0

1404.8

1.86

117

1166

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

286

1.05

0.06

1.9

1.8

—

(40765096) Chromosome analysis panel by Banding

121

0.91

0.06

1.3

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

415

1.04

0.05

1.6

1.7

—

(3025130) Human papilloma virus identified in Specimen

435

1.03

0.05

1.7

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

151

0.93

0.05

3.0

2.2

e6/l

552.3

666.5

—

106

(3051387) C reactive protein [Mass/volume] in Capillary blood

792

1.02

0.05

3.5

3.1

mg/l

23.5

27.2

0.54

479

(4198724)

110

0.91

0.05

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

199

1.06

0.04

2.0

1.6

—

(3024932) HLA-DR beta [Type]

150

1.07

0.04

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

170

1.06

0.04

1.7

3.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

805

1.02

0.04

3.2

3.9

u/ml

691.7

763.0

0.05

744

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

200

1.05

0.03

2.0

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

162

1.05

0.02

3.5

4.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

162

1.05

0.02

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

162

1.05

0.02

1.4

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

331

1.03

0.02

3.8

5.2

u/ml

25.4

62.7

1.51

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

670

1.02

0.02

1.3

1.2

u/ml

235.3

296.5

1.22

426

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

193

1.04

0.01

2.3

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

114

1.05

0.00

2.0

3.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

594

1.01

0.00

1.3

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

1.01

0.00

1.9

1.5

—

(3024471) HLA-A [Type]

155

1.03

0.00

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

778

1.00

0.00

1.4

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

415

0.99

0.00

1.1

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

113

0.97

0.00

1.7

1.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

137

1.02

0.00

3.0

2.0

e6/l

2712.9

19099.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

153

0.98

0.00

1.2

1.1

—

(3019977) pH of Arterial blood

203

0.99

0.00

1.8

2.8

7.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

131

0.99

0.00

1.2

1.5

umol/l

2.4

2.0

0.51

121

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

4.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

1.0

2.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.93

0.00

2.0

2.5

—

158.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

660

1.00

0.00

3.2

2.8

mmol/l

7.4

7.5

0.09

642

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

0.00

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.97

0.00

1.0

1.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.2

—

3.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.97

0.00

1.3

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.90

0.00

1.3

1.4

29.3

15.8

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(4038314)

0.00

0.0

1.4

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

7.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.96

0.00

2.4

3.3

mg/l

7.3

8.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

150

1.00

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ACHILLESTEND and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ACHILLESTEND	0.902 [0.8, 1.02]	0.095
Birth year	0.994 [0.99, 1.0]	0.166

During the follow-up period (1.1.1998 — 31.12.2019), 623 out of 9742 females with M13_ACHILLESTEND died.

Males

Parameter	HR [95% CI]	p-value
M13_ACHILLESTEND	0.776 [0.69, 0.87]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 892 out of 10400 males with M13_ACHILLESTEND died.

Mortality risk

Mortality risk for people of age

years, who have M13_ACHILLESTEND.

N-year risk	Females	Males
1	0.06%	0.109%
5	0.485%	0.708%
10	1.193%	1.932%
15	2.506%	3.762%
20	4.409%	6.826%

Relationships between endpoints

↥

Index endpoint: M13_ACHILLESTEND – Achilles tendinitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Achilles tendinitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints